In prostate cancer cell lines, PBX1-HOXC8 heterocomplex formation was shown to drive cell growth (Kikugawa et al., 2006); PBX1-mediated induction of cell proliferation and resistance against anti-cancer drugs was shown also in the patients’ cells (Liu Y. et al., 2019). The gene discussed is PBX1; the disease is prostate carcinoma.